2 hours Leerink Partnrs Analysts Lift Earnings Estimates for SAGEMarketBeat
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Leerink Partnrs increased their Q3 2024 earnings per share estimates for Sage Therapeutics in a research report issued to clients and investors on Tuesday, October 15th. Leerink Partnrs analyst M…
Earnings · Nasdaq 100 · Science
X